Churojana Anchalee, Chailerd Ornkamol, Mongkolratnan Atithep, Sangpetngam Boonrerk, Withayasuk Pattarawit, Chankaew Ekawut, Aurboonyawat Thaweesak, Songsaeng Dittapong
Department of Radiology, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Department of Surgery, Division of Neurosurgery, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Asian J Neurosurg. 2018 Jul-Sep;13(3):749-753. doi: 10.4103/ajns.AJNS_31_18.
To evaluate the effectiveness of dural venous sinus sacrifice as a treatment of aggressive type cranial dural arteriovenous fistulas (dAVFs) in terms of both clinical outcome and angiographic outcome.
One hundred and twenty-eight patients with 163 aggressive type cranial dAVFs who were treated with dural sinus sacrifice were retrospectively reviewed. Clinical and angiographic outcomes were analyzed. Procedural complications were also recorded. Only 103 patients (80.5%) who had been following up for at least 90 days were analyzed for clinical outcome.
There were 53 males and 75 females with age ranging from 20 years to 93 years (mean age 55.44 years). The overall angiographic cure rate of dural venous sinus sacrifice as a part of the treatment of aggressive dAVFs was 81.6%. Considering clinical outcome (average duration of follow-up was 2 years and 6 months), 75 patients (72.8%) had clinical improvement and 21 (20.4%) were clinically stable. Worsening of the presenting symptoms was observed in 7 patients (6.8%). Procedural complications were found in 5 patients (3.9%).
Dural venous sinus sacrifice is a safe and effective treatment strategy with high angiographic cure rate, good clinical outcome, and low incidence of procedural-related complication.
从临床结局和血管造影结局两方面评估硬脑膜静脉窦牺牲术治疗侵袭性颅内硬脑膜动静脉瘘(dAVF)的有效性。
回顾性分析128例接受硬脑膜静脉窦牺牲术治疗的163例侵袭性颅内dAVF患者。分析临床和血管造影结局。记录手术并发症。仅对103例(80.5%)随访至少90天的患者进行临床结局分析。
患者共128例,其中男性53例,女性75例,年龄20岁至93岁(平均年龄55.44岁)。作为侵袭性dAVF治疗一部分的硬脑膜静脉窦牺牲术的总体血管造影治愈率为81.6%。考虑临床结局(平均随访时间为2年6个月),75例(72.8%)患者临床症状改善,21例(20.4%)临床症状稳定。7例(6.8%)患者出现症状恶化。5例(3.9%)患者出现手术并发症。
硬脑膜静脉窦牺牲术是一种安全有效的治疗策略,血管造影治愈率高,临床结局良好,手术相关并发症发生率低。